Institutional Review Board (IRB) holds the primary responsibility for the oversight of the protection of human subjects recruited to participate or actively participating in research projects conducted by or under the auspices of California Pacific Medical Center, University of The Pacific, and SKERI.

Institutional Biosafety Committee (IBC) reviews all recombinant DNA studies to be carried out at California Pacific and ensure they are conducted according to the NIH Guidelines.

Office of Grants and Contracts supports CPMCRI researchers with information and resources related to obtaining and managing research.